Home / Forums / Q&A from Webinar: Model-informed Drug Repurposing – Applications for COVID-19 (May 14) / Webinar Q: 2 or 3 compartmental model comparison / Reply To: Webinar Q: 2 or 3 compartmental model comparison
Generally, these modeling efforts have undergone regulatory scrutiny when the compound is approved/licensed for the initial indication. So, we have very good information on what model is “best.”